Want to join the conversation?
Thousand Oaks, California-based biopharmaceutical company $AMGN reported 4Q15 net income of $1.8Bil, which grew 39% from 4Q14. GAAP EPS of $2.37 improved 41% from $1.68 last year. 4Q15 revenue increased 4% to $5.54Bil, with 3% product sales growth driven by Enbrel, Sensipar, Prolia, Kyprolis and XGEVA. Adjusted EPS grew 21% to $2.61 in 4Q15.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.